Well-characterized working cell Bank (WCB) of the NCL1 line (induced pluripotent stem cells reprogrammed from CD34+ umbilical cord blood cells under GMP conditions employing integration-free technology by introducing Yamanaka factors) grown and cryoprserved at Eyestem under license from a sample originally distributed for the NIH by RUCDR Infinite Biologics.
Well-characterized working cell Bank (WCB) of the GFP-expressing NCL1 line (induced pluripotent stem cells reprogrammed from CD34+ umbilical cord blood cells under GMP conditions employing integration-free technology by introducing Yamanaka factors) grown and cryopreserved at Eyestem under license from a sample originally distributed for the NIH by RUCDR Infinite Biologics.
Well-characterized (both in vitro and in vivo) Retinal Pigment Epithelium (RPE) cells generated de novo from human induced pluripotent stem cells (NCL1) employing Eyestem’s novel and unified differentiation protocol published recently (Methods Mol Biol. 2018 Jun 13).